Abstract
Metastasis is a multi-step process that is critically affected by cues from the tumor micro-environment (TME), such as from the extracellular matrix (ECM). The role of the ECM in the onset of metastasis, invasion, is not yet fully understood. A further complicating factor is that the ECM in the TME is mostly heterogeneous, in particular presenting a basement membrane (BM) directly enveloping the tumor, which acts as a barrier to invasion into the surrounding stromal ECM. To systematically investigate the role of ECM in invasion, appropriate in vitro models with control over such ECM heterogeneity are essential. We present a novel high-throughput microfluidic approach to build such a model, which enables to capture the invasion of cancer cells from the tumor, through the BM and into the stromal tissue. We used a droplet-maker device to encapsulate cells in beads of a primary hydrogel mimicking BM, Matrigel, which were then embedded in a secondary hydrogel mimicking stromal ECM, collagen I. Our technology ultimately provides control over parameters such as tissue size, cell count and type, and ECM composition and stiffness. As a proof-of-principle, we carried out a comparative study with two breast cancer cell types, and we observed typical behavior consistent with previous studies. Highly invasive MDA-MB-231 cells showed single cell invasion behavior, whereas poorly invasive MCF-7 cells physically penetrated the surrounding matrix collectively. A comparative analysis conducted between our heterogeneous model and previous models employing a single type of hydrogel, either collagen I or Matrigel, has unveiled a substantial difference in terms of cancer cell invasion distance. Our in vitro model resembles an in vivo heterogeneous cancer microenvironment and can potentially be used for high throughput studies of cancer invasion.
| Original language | English |
|---|---|
| Article number | 1267021 |
| Number of pages | 16 |
| Journal | Frontiers in Bioengineering and Biotechnology |
| Volume | 11 |
| DOIs | |
| Publication status | Published - 2023 |
Funding
The authors declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the Institute of Complex Molecular Systems (ICMS), European project Moore4Medical (10028031), and by the European Union through a Marie Curie Career Integration Grant (618623). Moore4Medical has received funding within the Electronic Components and Systems for European Leadership Joint Undertaking (ECSEL JU) in collaboration with the European Union’s H2020 Framework Programme (H2020/2014-2020) and National Authorities, under grant agreement H2020-ECSEL-2019-IA-876190 www.moore4medical.eu .
| Funders | Funder number |
|---|---|
| European Union's Horizon 2020 - Research and Innovation Framework Programme | H2020/2014-2020 |
| Institute for Complex Molecular Systems | 10028031 |
| European Commission | 618623 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- cancer-on-a-chip
- extracellular matrix
- heterogeneous ECM
- microfluidics
- tumor invasion
- tumor micro-environment
Fingerprint
Dive into the research topics of 'An in vitro model of cancer invasion with heterogeneous ECM created with droplet microfluidics'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver